🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesArterial stiffness reduction on GLP-1 — need advice Page 3

Arterial stiffness reduction on GLP-1 — need advice

tony_orlando Tue, Sep 2, 2025 at 11:44 AM 16 replies 1,244 viewsPage 3 of 4
SteveThurs
Member
523
2,345
Sep 2024
Wisconsin
Online
Sep 4, 2025 at 2:50 AM#11
NurseAsh_DET said:
Dr.GastroMayo said: ...we're creating a generation dependent on cardiovascular risk...

Genuinely useful, thank you. I had the facts and not the framework. Taking it to my next appointment.

17 17MaxMetOK, MounjBrad, nick_newbie and 14 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Sep 4, 2025 at 7:35 AM#12

From the other side of the consultation, briefly.

Dizziness and cardiovascular risk: I was lightheaded for the first 2 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

Last edited: Sep 4, 2025 at 1:35 PM
16 16mark_tokyo, hans_munich, jason_sac26 and 13 others
Reply Quote Save Share Report
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Sep 4, 2025 at 12:20 PM#13
traveltech_sara said:
6 month update on cardiovascular risk: down 48 lbs, off blood pressure meds, A1C normalized.

Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 → elevated homocysteine → increased cardiovascular risk marker.

The connection: B12 is a cofactor for homocysteine metabolism. Without adequate B12, homocysteine accumulates. This is ironic — taking a CV-protective medication while developing a CV risk factor from reduced nutrition.

Solution: comprehensive vitamin supplementation and regular lab monitoring. Don't let the medication's benefits be undermined by nutritional deficiencies.

Last edited: Sep 4, 2025 at 2:20 PM
15 15LibrarianMeg, bri_stats, pete_manc_UK and 12 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Sep 4, 2025 at 5:05 PM#14
tony_orlando said:
SELECT is the trial that changed the framing of this class, because it was an outcome trial rather than a weight trial: about a 20% relative reduction…

Senior perspective on cardiovascular risk: I'm 63 years old and started this journey skeptically. My endocrinologist recommended it after years of failed interventions.

15 months later: down 36 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.

14 14FranDenver, Dr.BariatricHTX, LindaRN_retired and 11 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Sep 4, 2025 at 9:49 PM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Thread quality here is what the rules are for. Keep it up.

Last edited: Sep 4, 2025 at 11:49 PM
13 13PurityPaulOR, MaxMetOK, MounjBrad and 10 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register